U.S. Markets closed

ViewRay, Inc. (VRAY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9400-0.2300 (-5.52%)
At close: 4:00PM EDT

4.0100 +0.07 (1.78%)
After hours: 7:24PM EDT

ViewRay, Inc.

2 Thermo Fisher Way
Oakwood, OH 44146
United States
440 703 3210
http://www.viewray.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees236

Key Executives

NameTitlePayExercisedYear Born
Mr. Scott William DrakePres, CEO & Director1.23MN/A1968
Dr. James F. DempseyChief Scientific Officer468.31k1.16M1971
Mr. Zachary William StassenChief Financial OfficerN/AN/AN/A
Ms. Michaella GallinaSr. Director of Investor Relations & CommunicationsN/AN/AN/A
Mr. Robert S. McCormackSr. VP, Gen. Counsel & Corp. Sec.N/AN/AN/A
Karen HackstaffVP of MarketingN/AN/AN/A
Mr. Robert Michael FuchsChief HR OfficerN/AN/A1967
Dr. Martin FussChief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Corporate Governance

ViewRay, Inc.’s ISS Governance QualityScore as of April 1, 2021 is 9. The pillar scores are Audit: 4; Board: 6; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.